Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

CRISPR-edited megakaryocytes for rapid screening of platelet gene functions

Emilie Montenont, Seema Bhatlekar, Shancy Jacob, Yasuhiro Kosaka, Bhanu K. Manne, Olivia Lee, Ivan Parra-Izquierdo, Emilia Tugolukova, Neal D. Tolley, Matthew T. Rondina, Paul F. Bray, Jesse W. Rowley

Blood Adv (2021) 5 (9): 2362–2374.

https://doi.org/10.1182/bloodadvances.2020004112

Published: 2021

Includes: Supplemental data

Journal Articles

ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia

Kayleigh M. Gallagher, Justine E. Roderick, Shi Hao Tan, Tze King Tan, Leonard Murphy, Jun Yu, Rui Li, Kevin W. O’Connor, Julie Zhu, Michael R. Green, Takaomi Sanda, Michelle A. Kelliher

Blood Adv (2020) 4 (13): 3154–3168.

https://doi.org/10.1182/bloodadvances.2020001555

Published: 2020

Includes: Supplemental data

Journal Articles

TLR-mediated activation of Waldenström macroglobulinemia B cells reveals an uncoupling from plasma cell differentiation

Jennifer Shrimpton, Matthew A. Care, Jonathan Carmichael, Kieran Walker, Paul Evans, Charlotte Evans, Ruth de Tute, Roger Owen, Reuben M. Tooze, Gina M. Doody

Blood Adv (2020) 4 (12): 2821–2836.

https://doi.org/10.1182/bloodadvances.2019001279

Published: 2020

Includes: Supplemental data

Journal Articles

Loss of GPVI and GPIbα contributes to trauma-induced platelet dysfunction in severely injured patients

Paul Vulliamy, Samantha J. Montague, Scarlett Gillespie, Melissa V. Chan, Lucy A. Coupland, Robert K. Andrews, Timothy D. Warner, Elizabeth E. Gardiner, Karim Brohi, Paul C. Armstrong

Blood Adv (2020) 4 (12): 2623–2630.

https://doi.org/10.1182/bloodadvances.2020001776

Published: 2020

Includes: Supplemental data

Journal Articles

Inflammatory signaling in dengue-infected platelets requires translation and secretion of nonstructural protein 1

Anna Cecíllia Quirino-Teixeira, Stephane Vicente Rozini, Giselle Barbosa-Lima, Diego Rodrigues Coelho, Pedro Henrique Carneiro, Ronaldo Mohana-Borges, Patrícia T. Bozza, Eugenio D. Hottz

Blood Adv (2020) 4 (9): 2018–2031.

https://doi.org/10.1182/bloodadvances.2019001169

Published: 2020

Includes: Supplemental data

Journal Articles

Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies

Stephen M. Ansell, Ian Flinn, Matthew H. Taylor, Branimir I. Sikic, Joshua Brody, John Nemunaitis, Andrew Feldman, Thomas R. Hawthorne, Tracey Rawls, Tibor Keler, Michael J. Yellin

Blood Adv (2020) 4 (9): 1917–1926.

https://doi.org/10.1182/bloodadvances.2019001079

Published: 2020

Includes: Supplemental data

Journal Articles

GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets

Xi Chen, Shuchi Gupta, Matthew Cooper, Daniel DeHelian, Xuefei Zhao, Meghna U. Naik, Jeremy G. T. Wurtzel, Timothy J. Stalker, Lawrence E. Goldfinger, Jeffrey Benovic, Lawrence F. Brass, Steven E. McKenzie, Ulhas P. Naik, Peisong Ma

Blood Adv (2020) 4 (1): 76–86.

https://doi.org/10.1182/bloodadvances.2019000467

Published: 2020

Includes: Supplemental data

Journal Articles

Ether lipid metabolism by AADACL1 regulates platelet function and thrombosis

Stephen P. Holly, Nidhi Gera, Putianqi Wang, Alexander Wilson, Ziqiang Guan, Ling Lin, Brian Cooley, Hammodah R. Alfar, Ruchi G. Patil, Raymond Piatt, Tina M. Leisner, Wolfgang Bergmeier, Rinku Majumder, Leslie V. Parise

Blood Adv (2019) 3 (22): 3818–3828.

https://doi.org/10.1182/bloodadvances.2018030767

Published: 2019

Includes: Supplemental data

Journal Articles

Diacylglycerol kinase ζ is a negative regulator of GPVI-mediated platelet activation

Alyssa J. Moroi, Nicole M. Zwifelhofer, Matthew J. Riese, Debra K. Newman, Peter J. Newman

Blood Adv (2019) 3 (7): 1154–1166.

https://doi.org/10.1182/bloodadvances.2018026328

Published: 2019

Includes: Supplemental data

Journal Articles

ELMO1 deficiency enhances platelet function

Akruti Patel, John Kostyak, Carol Dangelmaier, Rachit Badolia, Dheeraj Bhavanasi, Joseph E. Aslan, Salim Merali, Soochong Kim, Johannes A. Eble, Lawrence Goldfinger, Satya Kunapuli

Blood Adv (2019) 3 (4): 575–587.

https://doi.org/10.1182/bloodadvances.2018016444

Published: 2019

Includes: Supplemental data

Journal Articles

Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation

Frederic Lagarrigue, Alexandre R. Gingras, David S. Paul, Andrew J. Valadez, Monica N. Cuevas, Hao Sun, Miguel A. Lopez-Ramirez, Benjamin T. Goult, Sanford J. Shattil, Wolfgang Bergmeier, Mark H. Ginsberg

Blood Adv (2018) 2 (18): 2358–2368.

https://doi.org/10.1182/bloodadvances.2018020487

Published: 2018

Includes: Supplemental data

Journal Articles

Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects

Constance C. F. M. J. Baaten, Frauke Swieringa, Tomasz Misztal, Tom G. Mastenbroek, Marion A. H. Feijge, Paul E. Bock, Marjo M. P. C. Donners, Peter W. Collins, Renhao Li, Paola E. J. van der Meijden, Johan W. M. Heemskerk

Blood Adv (2018) 2 (18): 2320–2331.

https://doi.org/10.1182/bloodadvances.2017011544

Published: 2018

Includes: Supplemental data

Journal Articles

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

Adrienne Sallets, Sophie Robinson, Adel Kardosh, Ronald Levy

Blood Adv (2018) 2 (17): 2230–2241.

https://doi.org/10.1182/bloodadvances.2018020040

Published: 2018

Includes: Supplemental data

Journal Articles

RGS10 shapes the hemostatic response to injury through its differential effects on intracellular signaling by platelet agonists

Peisong Ma, Shuchi Gupta, Sara Sampietro, Daniel DeHelian, Valerie Tutwiler, Alan Tang, Timothy J. Stalker, Lawrence F. Brass

Blood Adv (2018) 2 (16): 2145–2155.

https://doi.org/10.1182/bloodadvances.2017008508

Published: 2018

Includes: Supplemental data

Journal Articles

Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis

Manasa K. Nayak, Nirav Dhanesha, Prakash Doddapattar, Omar Rodriguez, Vijay K. Sonkar, Sanjana Dayal, Anil K. Chauhan

Blood Adv (2018) 2 (15): 2029–2038.

https://doi.org/10.1182/bloodadvances.2018022392

Published: 2018

Includes: Supplemental data

Journal Articles

Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets

Caterina Casari, David S. Paul, Sophie Susen, Cécile Lavenu-Bombled, Annie Harroche, Raymond Piatt, Kathryn O. Poe, Robert H. Lee, Marijke Bryckaert, Olivier D. Christophe, Peter J. Lenting, Cécile V. Denis, Wolfgang Bergmeier

Blood Adv (2018) 2 (12): 1417–1428.

https://doi.org/10.1182/bloodadvances.2017014290

Published: 2018

Includes: Supplemental data

Journal Articles

A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant

Shauna L. French, Claudia Thalmann, Paul F. Bray, Lynn E. Macdonald, Andrew J. Murphy, Mark W. Sleeman, Justin R. Hamilton

Blood Adv (2018) 2 (11): 1283–1293.

https://doi.org/10.1182/bloodadvances.2017015552

Published: 2018

Includes: Supplemental data

Journal Articles

Activation of the vitamin D receptor transcription factor stimulates the growth of definitive erythroid progenitors

Jeffrey Barminko, Brad M. Reinholt, Alexander Emmanuelli, Alannah N. Lejeune, Margaret H. Baron

Blood Adv (2018) 2 (11): 1207–1219.

https://doi.org/10.1182/bloodadvances.2018017533

Published: 2018

Includes: Supplemental data

Journal Articles

Coordination of platelet agonist signaling during the hemostatic response in vivo

Jian Shen, Sara Sampietro, Jie Wu, Juan Tang, Shuchi Gupta, Chelsea N. Matzko, Chaojun Tang, Ying Yu, Lawrence F. Brass, Li Zhu, Timothy J. Stalker

Blood Adv (2017) 1 (27): 2767–2775.

https://doi.org/10.1182/bloodadvances.2017009498

Published: 2017

Includes: Supplemental data

Journal Articles

TLR2 agonism reverses chemotherapy-induced neutropenia in Macaca fascicularis

Nicholas J. Laping, Michael P. DeMartino, Joshua E. Cottom, Jeffrey M. Axten, John G. Emery, Jeffrey H. Guss, Miriam Burman, James J. Foley, Mui Cheung, Allen Oliff, Sanjay Kumar

Blood Adv (2017) 1 (26): 2553–2562.

https://doi.org/10.1182/bloodadvances.2017010611

Published: 2017

NARROW

CRISPR-edited megakaryocytes for rapid screening of platelet gene functions

ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia

TLR-mediated activation of Waldenström macroglobulinemia B cells reveals an uncoupling from plasma cell differentiation

Loss of GPVI and GPIbα contributes to trauma-induced platelet dysfunction in severely injured patients

Inflammatory signaling in dengue-infected platelets requires translation and secretion of nonstructural protein 1

Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies

GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets

Ether lipid metabolism by AADACL1 regulates platelet function and thrombosis

Diacylglycerol kinase ζ is a negative regulator of GPVI-mediated platelet activation

ELMO1 deficiency enhances platelet function

Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation

Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

RGS10 shapes the hemostatic response to injury through its differential effects on intracellular signaling by platelet agonists

Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis

Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets

A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant

Activation of the vitamin D receptor transcription factor stimulates the growth of definitive erythroid progenitors

Coordination of platelet agonist signaling during the hemostatic response in vivo

TLR2 agonism reverses chemotherapy-induced neutropenia in Macaca fascicularis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only